Immunic, Inc.
IMUX· Nasdaq
Released Aug 3, 2020, before the open
10-Q filed Aug 3, 2020, 34 days after period end · 0001280776-20-000024
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$11.46M | -$14.71M | -$2.67M | -$12.41M |
| EPS Diluted | -$0.90 | -$1.52 | -$3.15 | -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR